Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells
Open Access
- 6 October 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (60) , 101509-101519
Abstract
Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cellsKeywords
This publication has 37 references indexed in Scilit:
- The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in VivoInternational Journal of Molecular Sciences, 2013
- Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivoOncology Reports, 2013
- Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cellsBMC Cancer, 2012
- A20 Modulates Lipid Metabolism and Energy Production to Promote Liver RegenerationPLOS ONE, 2011
- Emerging roles of E2Fs in cancer: an exit from cell cycle controlNature Reviews Cancer, 2009
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding ProteinCell, 2009
- Atypical E2Fs: new players in the E2F transcription factor familyTrends in Cell Biology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic DevelopmentDevelopmental Cell, 2008